{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33735717",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "05",
    "Day": "26"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "02",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.intimp.2021.107543",
      "S1567-5769(21)00179-X"
    ],
    "Journal": {
      "ISSN": "1878-1705",
      "JournalIssue": {
        "Volume": "95",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun"
        }
      },
      "Title": "International immunopharmacology",
      "ISOAbbreviation": "Int Immunopharmacol"
    },
    "ArticleTitle": "Covid-19 challenges to immune investigations and therapies.",
    "Pagination": {
      "StartPage": "107543",
      "MedlinePgn": "107543"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: jtalmadg@unmc.edu."
          }
        ],
        "LastName": "Talmadge",
        "ForeName": "James E",
        "Initials": "JE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre de Recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval, Qu\u00e9bec, QC G1V 4G2, Canada. Electronic address: francois.marceau@crchudequebec.ulaval.ca."
          }
        ],
        "LastName": "Marceau",
        "ForeName": "Francois",
        "Initials": "F"
      }
    ],
    "PublicationTypeList": [
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Int Immunopharmacol",
    "NlmUniqueID": "100965259",
    "ISSNLinking": "1567-5769"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "etiology",
        "immunology",
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology",
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunomodulation"
    },
    {
      "QualifierName": [
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}